Methods | Randomised, double‐blind trial. Random number sequence generated from a random number table. A numbered strip containing the capsules given to participating women. Masking achieved by giving each woman the active and corresponding placebo treatments. Side effects were assessed by women | |
Participants | 465 healthy women attending Utrecht State University Hospital, the Netherlands Included women with regular menstrual periods, who had had a single act of unprotected intercourse Excluded women who were breastfeeding, on medications and difficult to follow up |
|
Interventions | Yuzpe (ethinyl oestradiol 100 μg + norgestrel 1 mg, repeated after 12 h) on day 1 + placebo capsules for 4 days vs ethinyl oestradiol 5 mg dose followed by a placebo capsule 12 h later followed by ethinyl oestradiol 5 mg single daily dose for 4 days | |
Outcomes | Observed number of pregnancies, side effects and changes in menstrual pattern | |
Notes |
|
|
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Low risk | "By using a table of random numbers, 465 women were given one of the two treatments." |
Allocation concealment (selection bias) | Unclear risk | Allocation concealment method not explained |
Blinding (performance bias and detection bias) All outcomes | Low risk | "Double blinded". "In the high‐dose estrogen treatment, the second capsule was inert, whereas in the EE + NG combination treatment, the capsules to be taken after the first day were placebo. In this fashion strips of wrapped capsules with a similar appearance were used throughout the study." |
Incomplete outcome data (attrition bias) All outcomes | Unclear risk | Exact number of loss to follow‐up is not clear |
Selective reporting (reporting bias) | Low risk | Planned outcome of pregnancy and side effects were reported and I am unclear on how they chose how many they analysed in each outcome |
Other bias | Low risk | None detected |